New eczema drug shows promise in Mid-Stage trial
NCT ID NCT07037901
First seen Oct 31, 2025 · Last updated May 10, 2026 · Updated 25 times
Summary
This study tests an experimental drug called IMG-007 for adults with moderate-to-severe eczema (atopic dermatitis) that hasn't responded well to topical treatments. About 220 participants will receive either IMG-007 or a placebo to see if the drug safely reduces skin symptoms like redness and itching. The main goal is to measure improvement in eczema severity after 20 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Antelope Valley Clinical Trials
RECRUITINGLancaster, California, 93534, United States
-
Apex Clinical Research Center
RECRUITINGMayfield Heights, Ohio, 44124, United States
-
Arlington Dermatology
RECRUITINGRolling Meadows, Illinois, 60008, United States
-
ClinOhio Research Services LLC.
RECRUITINGColumbus, Ohio, 43213, United States
-
Darst Dermatology
RECRUITINGCharlotte, North Carolina, 28277, United States
-
DermEdge Research
RECRUITINGMississauga, Ontario, L4Y 4C5, Canada
-
Dermatology of Seattle & Bellevue
RECRUITINGBurien, Washington, 698168, United States
-
Dr. Chin-ho-Hong Medical Inc.
RECRUITINGSurrey, British Columbia, V3R 6A7, Canada
-
Forest Hills Dermatology Group
RECRUITINGKew Gardens, New York, 11415, United States
-
Inmagene Site 1
RECRUITINGNew York, New York, 10029, United States
-
Innovaderm Research Inc.
RECRUITINGMontreal, Quebec, H2X 2V1, Canada
-
North Bay Dermatology Centre
RECRUITINGNorth Bay, Ontario, P1B 3Z7, Canada
-
Oregon Dermatology and Research Center
RECRUITINGPortland, Oregon, 97210, United States
-
PacificDerm
RECRUITINGVancouver, British Columbia, V6H 4B1, Canada
-
Palm Harbor Dermatology PA d/b/a TrueBlue Clinical Research
RECRUITINGTampa, Florida, 33609, United States
-
Palmetto Clinical Trial Services, LLC
RECRUITINGAnderson, South Carolina, 29621, United States
-
Red River Research Partners, LLC
RECRUITINGFargo, North Dakota, 58103, United States
-
Renstar Medical Research
RECRUITINGOcala, Florida, 34470, United States
-
Skinsense Medical Research
RECRUITINGSaskatoon, Saskatchewan, S7K 2C1, Canada
-
Stryde Research-Epiphany Dermatology
RECRUITINGSouthlake, Texas, 76092, United States
-
Sudbury Skin Clinique
RECRUITINGGreater Sudbury, Ontario, P3C 1X8, Canada
-
UCLA Division of Dermatology
RECRUITINGLos Angeles, California, 90095, United States
-
Vitality Clinical Trials LLC
RECRUITINGWoodbury, New York, 11797, United States
Conditions
Explore the condition pages connected to this study.